Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : REPR - REPRO MED SYSTEMS INC -- Ignore unavailable to you. Want to Upgrade?

To: brogan who wrote (29)	9/11/2000 11:11:36 PM
From: SgtPepper	Respond to of 37

I agree! Been watching with interest and waiting for a pullback to add to my much-too-small position.

To: brogan who wrote (29)	11/14/2000 4:53:53 PM
From: honjohn007	Read Replies (2) \| Respond to of 37

HELLO OUT THERE>>>>>>>>>>> News today: Repro-Med Systems Announces Medicare Approval of Res-Q-Vac Airway Suction System November 14, 2000 9:30am Source: Business Wire CHESTER, N.Y., Nov 14, 2000 (BUSINESS WIRE) -- Repro-Med Systems Inc. (OTCBB:REPR) has been notified by Health Care Financing Administration (HCFA) that its Res-Q-Vac Oral Vacuum Suction System has been approved for reimbursement for home-care use under miscellaneous durable medical equipment code E1399. The sterile catheters are approved for tracheal suction, code A4624, and for oropharyngeal suction, code A4628. The Res-Q-Vac is a hand-operated, portable, lightweight suctioning device and can be used at home for suctioning patients with tracheotomies, swallowing disorders, excessive fluid or phlegm, Cerebal Palsy and any time suction is needed in the naso-pharynx. The Res-Q-Vac is totally portable and non-electric, providing complete mobility. "The use of the Res-Q-Vac at home represents tremendous value and efficacy to patients in home care," commented Andy Sealfon, president of Repro-Med Systems Inc. "While patients get the benefit of portability and quality of care, insurance carriers will appreciate the huge reduction in the cost of providing suction equipment to these patients. This market is potentially larger than the Emergency Medical Market we are presently selling due to the actual amount of suctioning done in the home." Typical costs of conventional electric suction run in the hundreds of dollars, while the home-care version of the Res-Q-Vac complete with sterile catheters and vial is priced at less than $80. For further information, visit the company's Web site at repro-med.com. THIS news release contains certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) and information relating to Repro-Med Systems Inc. that are based on the beliefs of the management of Repro-Med Systems Inc. as well as assumptions made by and information currently available to the management of Repro-Med Systems Inc. The company's actual results may vary materially from the forward-looking statements made in this report due to important factors such as: recent operating losses; uncertainties associated with future operating results; unpredictability related to Food and Drug Administration regulations; introduction of competitive products; limited liquidity; reimbursement-related risks; government regulation of the home health-care industry; success of the research and development effort; market acceptance of FREEDOM60; availability of sufficient capital to continue operations; and dependence on key personnel. When used in this news release, the words "estimate," "project," "believe," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. Such statements reflect the current views of Repro-Med Systems Inc. with respect to future events based on currently available information and are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Repro-Med does not undertake any obligation to release publicly any revision to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. CONTACT: Repro-Med Systems Inc., Chester Andy Sealfon, 914/469-2042